//
Cost-Effectiveness of Different Durations of Dual-Antiplatelet Use After Percutaneous Coronary Intervention
Effect of Luseogliflozin on Heart Failure With Preserved Ejection Fraction in Patients With Diabetes Mellitus
Timing of intervention in asymptomatic patients with valvular heart disease
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF
Prevalence and clinical implications of valvular calcification on coronary computed tomography angiography
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
Optical Frequency Domain Imaging Versus Intravascular Ultrasound in Percutaneous Coronary Intervention (OPINION Trial) Results From the OPINION Imaging Study
DAPT, Our Genome and Clopidogrel